Spontaneous remission from RAEB in a child

TO THE EDITOR
The term myelodysplastic syndromes (MDS) includes a group of hematologic disorders characterized by cytopenia of various degrees, in combination with a hypercellular bone marrow showing dysplastic changes. Current knowledge in this field, as to pediatric cases, lags behind that of childhood acute leukemias as a consequence of many concurrent factors including lower incidence, uncertain classification, difficult diagnosis, variability of the clinical picture, some possibly associated conditions and the lack of consistent cytogenetic abnormalities specific to a single disorder. 1, 2 Refractory anemia (RA), RA with excessive blasts (RAEB), RAEB in transformation (RAEB-T), RA with ringed sideroblasts (RARS), and chronic myelomonocytic leukemia (CMML, recently named JMML), 3 are the main categories of MDS as set out in the French-American-British (FAB) classification. 4 RAEB accounts for about one quarter of all MDS cases. The main features of RAEB are median age at presentation of 7 years, blast cells Ͻ5%, dysplasia and cytopenia of two or more cell lines in the peripheral blood, granulocytic or erythroid hyperplasia, dysplasia of myeloid, erythroid and/or megakaryocytic cell lines in the bone marrow. 1, 2, 4 Standard treatment of childhood RAEB remains controversial. Most patients progress to develop acute leukemia. 2 In such patients intensive chemotherapy has been less successful than in acute myeloid leukemia because of refractory disease, as well as a high rate of toxic death, related to more prolonged cytopenia. 2 Therefore, myeloablative therapy supported by a bone marrow transplant may be necessary. 5, 6 Nevertheless, sporadic reports of spontaneous remission may challenge this approach. We report a long lasting spontaneous remission from RAEB in an infant.
RA, a female, born in August 1995, was first admitted to hospital at the age of 7 months because of persistent low-grade fever and weight loss (350 g over 2 weeks). She weighed 6.450 kg (between the 5th and 10th centiles for her age) and was 67 cm long (25-50th centiles). Small cervical lymph nodes were palpable. All tests were negative except for an abnormal white blood cell (WBC) count of 20 500/mm 3 and a urine culture which grew 5 000 000 CFU/ml of E. coli). She was successfully treated with antibiotics and discharged . Her ferritin concentration was 623 ng/ml, and that of serum IgG was above the normal range for her age (1091 mg/dl; n.v. 199-677 mg/dl). Screening for toxoplasma, rubella, cytomegalovirus and herpes-specific antibodies (TORCH) was negative. Bone marrow aspirate showed a hypercellular marrow with 65% myeloid cells (myeloblasts 1%, promyelocytes 3%, myelocytes 5%, metamyelocytes 24%, non-segmented 21%, segmented 11%, lymphocytes 25%) and 7% erythroid cells (proerythroblasts 1%, basophilic erythroblasts 2%) with a myeloid/erythroid (M/E) ratio of 9/1, and only two megakaryocytes per smear, some cell debris, one histiocyte and an increased number of eosinophilic cells. In vitro culture of bone marrow cells showed a stunted growth of CFU-E and CFU-GM while no spontaneous growth was observed. Neither Epstein-Barr virus nor parvovirus B19 genome was detected by PCR analysis. The child received packed red blood cells as the only therapy. One month later, leukocytosis (18 570/mm 3 ), with monocytosis (1600/mm 3 ), anemia (Hb 8.9 g/dl with MCV 77.9 fl) and thrombocytopenia (platelets 88 000/mm 3 ) were evident. Electrophoresis for screening of abnormal hemoglobin was negative; serum LDH concentration was 1378 mU/ml. Bone marrow aspirate showed further reduction of the erythroid lineage, with myeloid dysplasia, 7% monocytes, 10% undifferentiated blasts and no megakaryocytes. In vitro assay of bone marrow precursor cell sensitivity to G-CSF was normal; and no spontaneous growth of CFU-GM was observed in the absence of GM-CSF and IL-3 stimulation. Based on this picture a RAEB myelodysplasia was diagnosed. The child was not treated. At a follow-up 4 months later her blood count was: WBC 15 020/mm 3 , monocytes 1520/mm 3 , Hb 12.2 g/dl with MCV 83 fl, platelets 90 000/mm 3 . Bone marrow aspirate showed persistently stunted growth of the erythroid lineage, with myeloid dysplasia, 7% monocytes, 5% undifferentiated blasts and no megakaryocytes; in vitro studies showed no spontaneous growth of CFU-GM in the absence of GM-CSF and IL-3 stimulation. Screening for identification of clonal cells in the bone marrow by Humara and PGK assays was negative. A chromosome analysis on bone marrow, which had failed to give a result at onset, now demonstrated a normal karyotype in 25 mitoses. Six months later the blood count showed WBC 11 530/mm 3 , monocytes 450/mm 3 , Hb 13 g/dl with MCV 81 fl, thrombocytes 164 000/mm 3 . Bone marrow aspirate 857 showed normal cellularity and morphology of the erythroid and myeloid lineage. The marrow karyotype was still normal. In the following months the WBC and monocyte counts progressively normalized, as did the hemoglobin, platelet and ferritin levels. In vitro growth of CFU-GM and BFU-GM was normal. After this spontaneous remission, it is noteworthy that a chromosome analysis performed at the age of 4.2 years on peripheral blood unstimulated cultures, showed evidence of two out of 11 cells analyzed with a long arm deletion of chromosome 7: the technical level of the preparations did not permit a precise definition of the breakpoint(s). Five months later chromosome analysis was repeated on blood cultures, but no mitoses were found from unstimulated cultures, whereas PHA-stimulated ones showed a normal karyotype. At the latest follow-up, at the age of 5.3 years, the child remains completely asymptomatic with normal hematologic findings.
The presenting features of this child fulfilled the diagnostic criteria for RAEB-type childhood MDS, 8 a condition which is usually associated with a poor prognosis because of the strong probability of progression to acute leukemia. Nevertheless, the child had a very favorable clinical course with complete resolution of her clinical symptoms and of the marrow dysplasia. Spontaneous remission in adults with MDS has been reported sporadically. Dervenoulas et al 7 described the spontaneous clinical and cytogenetic remission from RAEB with trisomy 21 in an elderly patient, which lasted 6 months but was then followed by clinical and cytogenetic relapse. Two other cases of spontaneous clinical and cytogenetic remission of RAEB were reported, one after septicemia 8 and one in a case with monosomy 7 and trisomy 8. 9 Spontaneous remission in childhood has also been reported. A 14-month-old boy with RAEB and bone marrow monosomy 7, after three transfusions within the first 4 months of management, showed red cell production normalization, followed by reversal of neutropenia within 18 months and a disease-free follow-up of over 34 months. Molecular analysis of the bone marrow blasts showed no mutations of the ras or NF-1 genes. 10 Three cases are worthy of mention from a review by the French group: an 8-year-old girl with RA and a normal karyotype, had a bone marrow transplantation preceded by spontaneous remission which then persisted for over 3 years; a 5-year-old girl with sideroblastic anemia underwent spontaneous remission which likewise lasted for over 3 years; a 5-month-old girl with pancytopenia and dysmegakaryocytopoiesis spontaneously recovered completely normal hematopoiesis within 1 year of diagnosis and this state was still present 1 year later.
11 'Spontaneous' clinical and cytogenetic remission of RA with monosomy 7, secondary to chronic treatment with azathioprine, was induced by stopping the immune suppression, suggesting that recovery of better immunosurveillance may have a role in the control of clonal RA. 12 In our patient no evidence of chromosome anomalies was obtained at onset, and virological studies failed to document potential infectious causes such as EBV, CMV, HHV6, or parvovirus B19. After the spontaneous remission, and after two subsequent chromosome analyses which showed a normal marrow karyotype, two cells with a chromosome change, namely a chromosome 7 long arm deletion, were found in preparations from a blood unstimulated culture. We suggest that these two cells, with an anomaly quite frequent in MDS, might represent a remnant of an abnormal clone which could have been important at onset. On the basis of the results available we cannot state beyond any doubt that the anomaly is really clonal, but it is possible to postulate that the history of the MDS in our patient began with this chromosome 7 deletion, and that the spontaneous remission took place even in the presence of a marrow clone with this anomaly.
In conclusion, standard treatment of childhood RAEB remains controversial. Although in most cases early progression to acute leukemia suggests that an aggressive management approach would be appropriate, the paucity of systematic clinical reports together with evidence of some cases with a mild clinical course or even spontaneous clinical remission may suggest some caution, especially in cases in which there is no evidence of leukemic transformation. This might be the case even in patients, as the present one seems to be, with a clonal chromosome change.
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